All Insights
Showing 1 - 12 of 485
Life Sciences and Healthcare
EU MDR and IVDR poised to remain main framework for medical AI in draft AI interface reforms
Lex specialis treatment, integrated notified body reviews and clarified duties are designed to limit overlapping regulation of medical AI
Intellectual property
What trade mark and designs issues should brands look out for in Europe in 2026?
Non-use trade mark challenges may be on the rise, with bad faith and post-sale confusion remaining on the agenda and
Retail and Consumer
Sales in Belgium: key points to keep in mind before launching a promotional campaign
The winter sales have started, next will come the summer sales and, in between, consumers are constantly exposed to various
Life Sciences and Healthcare
EU digital by default medtech plans signal shift in submissions, product information and online sales
E-submissions, digital documentation and clarified Eudamed and UDI duties to steer medtech towards fuller digitalisation
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Regulatory Outlook
Products | UK Regulatory Outlook January 2026
General/digital products UK: Product Regulation and Metrology Act consultations and guidance | Government response to the independent review of the
Regulatory Outlook
Food law | UK Regulatory Outlook January 2026
UK: Developments in the UK-EU SPS agreement | Windsor Framework Committee reports progress on SPS implementation in NI | Precision
Regulatory Outlook
Digital regulation | UK Regulatory Outlook January 2026
UK Online Safety Act: fees, categorisation and enforcement | UK Media Act: a year dense with 'go‑live' dates | EU
Regulatory Outlook
Consumer law | UK Regulatory Outlook January 2026
UK DMCCA: Subscriptions and unfair commercial practices in focus | European Commission's 2030 Consumer Agenda
Regulatory Outlook
Advertising and marketing | UK Regulatory Outlook January 2026
Influencer marketing | AI disclosure and enforcement | Protection of children | Price transparency under the DMCCA | Subscriptions |
